The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2017

Filed:

Dec. 20, 2012
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Giorgio Caravatti, Bottmingen, CH;

Sylvie Chamoin, Saint Louis, FR;

Pascal Furet, Thann, FR;

Klemens Hogenauer, Oberwil, CH;

Konstanze Hurth, Lorrach, DE;

Karen Kammertoens, Village-Neuf, FR;

Ian Lewis, Riehen, CH;

Henrik Moebitz, Freiburg, DE;

Alexander Baxter Smith, Niffer, FR;

Nicolas Soldermann, Village-Neuf, FR;

Romain Wolf, Schlierbach, FR;

Frederic Zecri, Brookline, MA (US);

Assignee:

NOVARTIS AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/04 (2006.01); A61K 31/538 (2006.01); A61K 31/5383 (2006.01); C07D 413/14 (2006.01); C12Q 1/25 (2006.01); C12N 9/12 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/538 (2013.01); C07D 413/14 (2013.01); C07D 498/04 (2013.01); C12N 9/12 (2013.01); C12Q 1/25 (2013.01); C12Q 1/686 (2013.01);
Abstract

The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R, R, Rand Rare as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.


Find Patent Forward Citations

Loading…